Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure

Clinical trial NCT02653482 · COMPLETED

Trial details

NCT number: NCT02653482
Sponsor: Saint Luke's Health System
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Heart Failure With Reduced Systolic Function

Start date: 2016-03-03
Primary completion: 2019-06-28
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.